Grand Launch! Comprehensive and Targeted Ablation: Shinerhythm RhythPulse® PFA System Debuts at CAFS 2025

【ShineyoMedical RhythPulse®-PFA System】

ShineyoMedical's RhythPulse®-PFA System is the first approved Pulse Field Ablation (PFA) system in China that integrates multi-channel, large focal, and targeted ablation, mainly used for treating rapid arrhythmias such as drug-refractory and recurrent atrial fibrillation. Its core advantages include:

      Large Focal Design:Using the world's first 10mm ring ablation catheter, a single discharge can cover a lesion area with a diameter of 10mm, improving the ablation efficiency by more than three times compared to traditional technology.

      Targeted Ablation Technology:Equipped with an intelligent contact detection module, it monitors the contact status between the electrode and myocardial tissue in real time, reducing the risk of hemolysis caused by ineffective discharge. Postoperative plasma free hemoglobin content decreased by 50%.

      Clinical Validation Excellence:In a clinical trial involving 151 cases, the immediate success rate was 100%, and the success rate for atrial fibrillation treatment at 12 months post-operation reached 85.07%, achieving internationally leading standards. — ShineyoMedical